{"id":"W2049360002","doi":"10.1182/blood.v99.8.2845","title":"Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu–overexpressing cancers","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":84,"is_retracted":false,"has_abstract":true,"ca_institutions":"Research & Development Corporation","funders":"National Center for Research Resources; National Cancer Institute","keywords":"HER2/neu; Adjuvant; Medicine; Ex vivo; Cancer vaccine; Immunology; Peptide vaccine; In vivo; Granulocyte macrophage colony-stimulating factor; Dendritic cell; Immune system; Spleen; Internal medicine; Antigen; Immunotherapy; Cancer research; Cancer; Cytokine; Biology; Epitope; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005052447,0.0003022804,0.0006864494,0.0002002247,0.0002550443,0.0003146649,0.0002197507,0.0004181841,0.0004409674],"category_scores_gemma":[0.0006927592,0.0001449565,0.0002877276,0.0002145436,0.0002341747,0.0003509205,0.0001498798,0.0005725182,0.0001284527],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006187866,"about_ca_system_score_gemma":0.0006460019,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006604925,"about_ca_topic_score_gemma":0.001105054,"domain_scores_codex":[0.999836,0.00007107647,0.00001118125,0.00002255072,0.00001775548,0.00004145167],"domain_scores_gemma":[0.9998376,0.00005175965,0.00003466436,0.0000101224,0.000009152743,0.00005664305],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.09275512,0.01638173,0.1070229,0.0009584165,0.0005959122,0.004703348,0.001128261,0.01257131,0.2008836,0.001380988,0.005526542,0.5560918],"study_design_scores_gemma":[0.0444432,0.5908666,0.1992074,0.0002067323,0.001535929,0.0113267,0.0003830066,0.01656003,0.09752974,0.001419564,0.03641136,0.0001097239],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956462,0.002551749,0.0002913098,0.0003164799,0.000035457,0.0001576845,0.0000550842,0.00003409723,0.0009120099],"genre_scores_gemma":[0.9982496,0.0005053026,0.0004856397,0.0002557139,0.0000451222,0.00009510367,0.0000973705,0.000003873565,0.0002622441],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006864494,"threshold_uncertainty_score":0.004489601,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004956351801242701,"score_gpt":0.192548234932947,"score_spread":0.1875918831317042,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}